Literature DB >> 20307545

Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen.

Norman R Watts1, Joe G Vethanayagam, R Bridget Ferns, Richard S Tedder, Audray Harris, Stephen J Stahl, Alasdair C Steven, Paul T Wingfield.   

Abstract

The hepatitis B virus core gene codes for two closely related antigens: a 21-kDa protein that forms dimers that assemble as multimegadalton capsids, and a 17-kDa protein that also forms dimers but that do not assemble. The proteins, respectively referred to as core antigen (HBcAg) and e-antigen (HBeAg), share a sequence of 149 residues but have different amino- and carboxy-termini. Their structural and serological relationship has long been unclear. With insights gained from recent structural studies on immune complexes of the capsids, the relationship was reassessed using recombinant forms of the antigens and a panel of monoclonal antibodies (mAbs) commonly believed to discriminate between core and e-antigen. Surface plasmon resonance (SPR) was used to measure the affinities, in contrast to previous studies that used more error-prone and less sensitive plate-type assays. Four of the six mAbs did not discriminate between core and e-antigen, nor did they discriminate between e-antigen and dimers of dissociated core antigen capsids. One mAb (3120) was specific for assembled capsids and one (e6) was specific for unassembled dimers. Epitope valency of the e-antigen was also studied, using a sandwich SPR assay where e-antigen was captured with one mAb and probed with a second. The e-antigen is often considered to be a monomeric protein on the basis of monovalent reactivity with antibody pairs specific for either an alpha or beta epitope (in a prior nomenclature for e-antigen specificity). This model, however, is incorrect, because recombinant e-antigen is a stable dimer and its apparent monovalency is due to steric blockage. This was proven by the formation of a 2:1 Fab e6-e-antigen complex. These results suggest new approaches for the isolation of the authentic e-antigen, its biological assay, and its stabilization as an immune complex for structural studies. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307545      PMCID: PMC2860019          DOI: 10.1016/j.jmb.2010.03.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

Review 1.  Valency of antibody binding to virions and its determination by surface plasmon resonance.

Authors:  Nigel J Dimmock; Sam A Hardy
Journal:  Rev Med Virol       Date:  2004 Mar-Apr       Impact factor: 6.989

2.  Human and monoclonal antibodies to hepatitis B core antigen recognise a single immunodominant epitope.

Authors:  R B Ferns; R S Tedder
Journal:  J Med Virol       Date:  1986-06       Impact factor: 2.327

3.  Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.

Authors:  J Salfeld; E Pfaff; M Noah; H Schaller
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 4.  Molecular biology of hepatitis B virus e antigen.

Authors:  J H Ou
Journal:  J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 4.029

5.  A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes.

Authors:  D N Standring; J H Ou; F R Masiarz; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Authors:  F Schödel; A M Moriarty; D L Peterson; J A Zheng; J L Hughes; H Will; D J Leturcq; J S McGee; D R Milich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

Authors:  M Imai; M Nomura; T Gotanda; T Sano; K Tachibana; H Miyamoto; K Takahashi; S Toyama; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Duality of hepatitis B e antigen in serum of persons infected with hepatitis B virus: evidence for the nonidentity of e antigen with immunoglobulins.

Authors:  K Takahashi; M Imai; Y Miyakawa; S Iwakiri; M Mayumi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

9.  Immunochemical structure of hepatitis B e antigen in the serum.

Authors:  K Takahashi; A Machida; G Funatsu; M Nomura; S Usuda; S Aoyagi; K Tachibana; H Miyamoto; M Imai; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Monoclonal antibodies to hepatitis Be antigen (HBeAg) derived from hepatitis B core antigen (HBcAg): their use in characterization and detection of HBeAg.

Authors:  R B Ferns; R S Tedder
Journal:  J Gen Virol       Date:  1984-05       Impact factor: 3.891

View more
  8 in total

1.  Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.

Authors:  Xiaolei Zhuang; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Altaira D Dearborn; Joni L Trenbeath; Elif Eren; Alasdair C Steven; Christoph Rader; Paul T Wingfield
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

2.  Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids.

Authors:  Jessica Z Bereszczak; Marlene Havlik; Victor U Weiss; Martina Marchetti-Deschmann; Esther van Duijn; Norman R Watts; Paul T Wingfield; Guenter Allmaier; Alasdair C Steven; Albert J R Heck
Journal:  Anal Bioanal Chem       Date:  2013-12-20       Impact factor: 4.142

Review 3.  Core protein: A pleiotropic keystone in the HBV lifecycle.

Authors:  Adam Zlotnick; Balasubramanian Venkatakrishnan; Zhenning Tan; Eric Lewellyn; William Turner; Samson Francis
Journal:  Antiviral Res       Date:  2015-06-27       Impact factor: 5.970

4.  Assessment of differences in the conformational flexibility of hepatitis B virus core-antigen and e-antigen by hydrogen deuterium exchange-mass spectrometry.

Authors:  Jessica Z Bereszczak; Norman R Watts; Paul T Wingfield; Alasdair C Steven; Albert J R Heck
Journal:  Protein Sci       Date:  2014-04-17       Impact factor: 6.725

5.  Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; Alasdair C Steven; Paul T Wingfield
Journal:  J Mol Biol       Date:  2011-04-02       Impact factor: 5.469

6.  Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.

Authors:  Weimin Wu; Zhaochun Chen; Naiqian Cheng; Norman R Watts; Stephen J Stahl; Patrizia Farci; Robert H Purcell; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2012-10-16       Impact factor: 2.867

7.  Expression of quasi-equivalence and capsid dimorphism in the Hepadnaviridae.

Authors:  Weimin Wu; Norman R Watts; Naiqian Cheng; Rick Huang; Alasdair C Steven; Paul T Wingfield
Journal:  PLoS Comput Biol       Date:  2020-04-20       Impact factor: 4.475

8.  Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Jonathan M Grimes; Alasdair C Steven; David I Stuart; Paul T Wingfield
Journal:  Structure       Date:  2012-12-06       Impact factor: 5.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.